Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIb Prospective, Multi-center, Randomized, Parallel, Double Blind, Placebo Controlled Trial to Evaluate Defibrotide Intravenous Infusion in the Prevention and Treatment of COVID-19 Respiratory Distress and Cytokine Release Syndrome

NCT04348383 is registered in ClinicalTrials.gov with Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia as lead sponsor.

NCT NCT04348383
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04348383 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIb Prospective, Multi-center, Randomized, Parallel, Double Blind, Placebo Controlled Trial to Evaluate Defibrotide Intravenous Infusion in the Prevention and Treatment of COVID-19 Respiratory Distress and Cytokine Release Syndrome
Lead sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Phase
Phase 2
Overall status
Completed
Start date
April 8, 2020
Completion date
February 28, 2023
Enrollment
156 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid19